Literature DB >> 27088251

Cutaneous Leishmaniasis and Conflict in Syria.

Waleed S Al-Salem, David M Pigott, Krishanthi Subramaniam, Lee Rafuse Haines, Louise Kelly-Hope, David H Molyneux, Simon I Hay, Alvaro Acosta-Serrano.   

Abstract

Entities:  

Keywords:  Cutaneous leishmaniasis; Leishmania; Phlebotomus; Syria; parasites; refugee camps; sand fly; vector-borne infections

Mesh:

Year:  2016        PMID: 27088251      PMCID: PMC4861536          DOI: 10.3201/eid2205.160042

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: War, infection, and disease have always made intimate bedfellows, with disease recrudescence characterizing most conflict zones (). Recently, increasing violence from civil war and terrorist activity in the Middle East has caused the largest human displacement in decades. A neglected consequence of this tragedy has been the reemergence of a cutaneous leishmaniasis epidemic. Old World cutaneous leishmaniasis is one of the most prevalent insectborne diseases within the World Health Organization’s Eastern Mediterranean Region (). Zoonotic cutaneous leishmaniasis is caused by the protozoan parasite Leishmania major, which is transmitted through the infectious bite of the female Phlebotomus papatasi sand fly; the animal reservoirs are the rodent genera Rhombomys, Psammomys, and Meriones. Anthroponotic cutaneous leishmaniasis is caused by L. tropica and transmitted between humans by the Ph. sergenti sand fly. Until 1960, cutaneous leishmaniasis prevalence in Syria was restricted to 2 areas to which it is endemic (Aleppo and Damascus); preconflict (c. 2010) incidence was 23,000 cases/year (). However, in early 2013, an alarming increase to 41,000 cutaneous leishmaniasis cases was reported (,). The regions most affected are under Islamic State control; 6,500 cases occurred in Ar-Raqqah, Diyar Al-Zour, and Hasakah. Because these places are not historical hotspots of cutaneous leishmaniasis, this change might be attributed to the massive human displacement within Syria and the ecologic disruption of sand fly (Ph. papatasi) habitats. According to the United Nations High Commissioner for Refugees, >4.2 million Syrians have been displaced into neighboring countries; Turkey, Lebanon, and Jordan have accepted most of these refugees. As a result, cutaneous leishmaniasis has begun to emerge in areas where displaced Syrians and disease reservoirs coexist (). According to the Lebanese Ministry of Health, during 2000–2012, only 6 cutaneous leishmaniasis cases were reported in Lebanon. However in 2013 alone, 1,033 new cases were reported, of which 96.6% occurred among the displaced Syrian refugee populations (). Similarly in Turkey, nonendemic parasite strains L. major and L. donovani were introduced by incoming refugees (). Many of the temporary refugee settlements are predisposed to increased risk because of malnutrition, poor housing, absence of clean water, and inadequate sanitation. The combination of favorable climate, abundant sand fly populations, displaced refugees, and deficient medical facilities and services has created an environment conducive to cutaneous leishmaniasis reemergence. For example, refugee settlements in Nizip in southern Turkey have reported several hundred cases (). Using current datasets published in English and Arabic, we mapped cutaneous leishmaniasis prevalence within Syria and its neighboring countries (Figure). Our results demonstrate that cutaneous leishmaniasis prevalence coincides with the presence of refugee camps (Figure, panel A), which is plausible given the strong association between disease outbreaks and refugee settlements (). The deterioration of Syrian health systems, including the cessation of countrywide vector control programs, has created an ideal environment for disease outbreaks (). Likewise, the sand fly vectors are widely distributed throughout the Middle East; expansive Ph. papatasi and Ph. sergenti sand fly populations exist in Syria and Iraq (). The presence of these vectors in regions of instability can create new cutaneous leishmaniasis foci, which might have debilitating, and often stigmatizing, consequences for residents and deployed military personnel (). In addition, the distribution of Leishmania spp. overlaps with sand fly habitats (Figure, panel B) and disease reservoirs (W. Al-Salem, unpub. data). Consequently, the movement of large refugee populations into regions that are ill-equipped to manage imported cutaneous leishmaniasis has resulted in outbreaks in Turkey and Lebanon (,).
Figure

Cutaneous leishmaniasis prevalence within Syria and neighboring countries of the World Health Organization’s Eastern Mediterranean Region, 2013. A) Prevalence among refugee camps. Case data were taken from http://datadryad.org/resource/doi:10.5061/dryad.05f5h. B) Distribution of sand fly and parasite species. Country names and boundaries are not official. Maps were adapted from https://hiu.state.gov/Products/Syria_DisplacementRefugees_2015Apr17_HIU_U1214.pdf.

Cutaneous leishmaniasis prevalence within Syria and neighboring countries of the World Health Organization’s Eastern Mediterranean Region, 2013. A) Prevalence among refugee camps. Case data were taken from http://datadryad.org/resource/doi:10.5061/dryad.05f5h. B) Distribution of sand fly and parasite species. Country names and boundaries are not official. Maps were adapted from https://hiu.state.gov/Products/Syria_DisplacementRefugees_2015Apr17_HIU_U1214.pdf. Our findings emphasize the importance of contemporaneous disease tracking to identify human populations at highest disease risk. To ameliorate the current cutaneous leishmaniasis crisis, particularly during the winter when cases start to appear, accurate disease monitoring and strategic training of persons based within refugee camps (medical staff, aid workers, volunteers, and military personnel) needs to be prioritized. Moreover, clinicians and other medical personnel residing in refugee-hosting countries must be suitably trained to diagnose cutaneous leishmaniasis because other local diseases (e.g., sarcoidosis and cutaneous tuberculosis) can have similar manifestations. Along with vector and rodent control, new cutaneous leishmaniasis outbreaks should be managed by prompt diagnosis and treatment, which are even more pertinent given that L. tropica–associated cutaneous leishmaniasis typically is resistant to several treatment regimens. In summary, the coexistence of sand fly populations and Leishmania spp. within refugee camps, together with the considerable influx of persons who already have cutaneous leishmaniasis, create a dangerous cocktail that can lead to an outbreak unprecedented in modern times.
  10 in total

1.  Cutaneous leishmaniasis in Syria: clinical features, current status and the effects of war.

Authors:  Kinan Hayani; Anwar Dandashli; Elke Weisshaar
Journal:  Acta Derm Venereol       Date:  2015-01       Impact factor: 4.437

2.  Cutaneous leishmaniasis and human conflict.

Authors:  Joanna M Fawcett; Roderick J Hay
Journal:  Acta Derm Venereol       Date:  2015-01       Impact factor: 4.437

3.  Endemic infectious diseases and biological warfare during the Gulf War: a decade of analysis and final concerns.

Authors:  K C Hyams; J Riddle; D H Trump; J T Graham
Journal:  Am J Trop Med Hyg       Date:  2001-11       Impact factor: 2.345

Review 4.  Syria: health in a country undergoing tragic transition.

Authors:  Ziyad Ben Taleb; Raed Bahelah; Fouad M Fouad; Adam Coutts; Meredith Wilcox; Wasim Maziak
Journal:  Int J Public Health       Date:  2014-07-15       Impact factor: 3.380

5.  The emergence of Leishmania major and Leishmania donovani in southern Turkey.

Authors:  Ismail S Koltas; Fadime Eroglu; Derya Alabaz; Soner Uzun
Journal:  Trans R Soc Trop Med Hyg       Date:  2014-01-20       Impact factor: 2.184

6.  Revisiting leishmaniasis in the time of war: the Syrian conflict and the Lebanese outbreak.

Authors:  Ali Alawieh; Umayya Musharrafieh; Amani Jaber; Atika Berry; Nada Ghosn; Abdul Rahman Bizri
Journal:  Int J Infect Dis       Date:  2014-10-24       Impact factor: 3.623

Review 7.  Leishmaniasis in an era of conflict in the Middle East.

Authors:  Raymond L Jacobson
Journal:  Vector Borne Zoonotic Dis       Date:  2010-09-16       Impact factor: 2.133

8.  Effect of the Syrian Civil War on Prevalence of Cutaneous Leishmaniasis in Southeastern Anatolia, Turkey.

Authors:  Rahime Inci; Perihan Ozturk; Mehmet Kamil Mulayim; Kemal Ozyurt; Emine Tugba Alatas; Mehmet Fatih Inci
Journal:  Med Sci Monit       Date:  2015-07-20

9.  Vaccine Science Diplomacy: Expanding Capacity to Prevent Emerging and Neglected Tropical Diseases Arising from Islamic State (IS)--Held Territories.

Authors:  Peter J Hotez
Journal:  PLoS Negl Trop Dis       Date:  2015-09-24

10.  Cutaneous leishmaniasis in the central provinces of Hama and Edlib in Syria: Vector identification and parasite typing.

Authors:  Nabil Haddad; Hanadi Saliba; Atef Altawil; Jeffrey Villinsky; Samar Al-Nahhas
Journal:  Parasit Vectors       Date:  2015-10-12       Impact factor: 3.876

  10 in total
  26 in total

1.  Visceral and Cutaneous Leishmaniases in a City in Syria and the Effects of the Syrian Conflict.

Authors:  Alexey Youssef; Rim Harfouch; Said El Zein; Zuheir Alshehabi; Rafea Shaaban; Souha S Kanj
Journal:  Am J Trop Med Hyg       Date:  2019-07       Impact factor: 2.345

Review 2.  Leishmaniasis: where are we and where are we heading?

Authors:  Santanu Sasidharan; Prakash Saudagar
Journal:  Parasitol Res       Date:  2021-04-07       Impact factor: 2.289

Review 3.  Microbial control of arthropod-borne disease.

Authors:  Miguel A Saldaña; Shivanand Hegde; Grant L Hughes
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-02       Impact factor: 2.743

Review 4.  Cutaneous Manifestations of Human and Murine Leishmaniasis.

Authors:  Breanna M Scorza; Edgar M Carvalho; Mary E Wilson
Journal:  Int J Mol Sci       Date:  2017-06-18       Impact factor: 5.923

Review 5.  The history of leishmaniasis.

Authors:  Dietmar Steverding
Journal:  Parasit Vectors       Date:  2017-02-15       Impact factor: 3.876

6.  An α-Gal-containing neoglycoprotein-based vaccine partially protects against murine cutaneous leishmaniasis caused by Leishmania major.

Authors:  Eva Iniguez; Nathaniel S Schocker; Krishanthi Subramaniam; Susana Portillo; Alba L Montoya; Waleed S Al-Salem; Caresse L Torres; Felipe Rodriguez; Otacilio C Moreira; Alvaro Acosta-Serrano; Katja Michael; Igor C Almeida; Rosa A Maldonado
Journal:  PLoS Negl Trop Dis       Date:  2017-10-25

7.  Chiclero's ulcer: An unusual presentation of Leishmania tropica in Syria.

Authors:  Alexey Youssef; Samar Yaseer; Rim Harfouch; Maya Marouf; Foz Hasan
Journal:  Avicenna J Med       Date:  2018 Jul-Sep

Review 8.  Vulnerabilities to and the Socioeconomic and Psychosocial Impacts of the Leishmaniases: A Review.

Authors:  Grace Grifferty; Hugh Shirley; Jamie McGloin; Jorja Kahn; Adrienne Orriols; Richard Wamai
Journal:  Res Rep Trop Med       Date:  2021-06-23

9.  Sounding the Alarm: Health in the Anthropocene.

Authors:  Colin D Butler
Journal:  Int J Environ Res Public Health       Date:  2016-06-30       Impact factor: 3.390

Review 10.  The cross-cutting contribution of the end of neglected tropical diseases to the sustainable development goals.

Authors:  Mathieu Bangert; David H Molyneux; Steve W Lindsay; Christopher Fitzpatrick; Dirk Engels
Journal:  Infect Dis Poverty       Date:  2017-04-04       Impact factor: 4.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.